NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Unraveling Parkinson’s Disease: Understanding, Coping, and Thriving
Parkinson's disease is a neurodegenerative disorder that affects millions worldwide, impacting movement, balance, and quality of life. At Countryside Neurology, [...]
Understanding Trigeminal Neuralgia: Symptoms, Causes, and Treatment Options
Trigeminal neuralgia is a debilitating condition characterized by intense facial pain originating from the trigeminal nerve, often described as sudden, [...]
Understanding Cervical Dystonia: Causes, Symptoms, and Treatment Options
Cervical dystonia, also known as spasmodic torticollis, is a neurological disorder characterized by involuntary muscle contractions in the neck, causing [...]
When Should You Visit a Neurologist? Recognizing Signs It’s Time for Expert Evaluation
As the body's command center, the brain and nervous system play a vital role in regulating various bodily functions, sensations, [...]
The Next Step in Alzheimer’s Care: The Potential of TMS Therapy in Cognitive Decline Management
Alzheimer's disease is a progressive neurological condition that affects millions of individuals worldwide, causing memory loss, cognitive decline, and impairment [...]
TMS Therapy: A Promising Frontier in Migraine Treatment and Prevention
Migraines affect millions of individuals worldwide, causing debilitating pain and disrupting daily activities. While traditional migraine treatments such as medication [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social